Articoli di riviste sul tema "Prognostic markers"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Vedi i top-50 articoli di riviste per l'attività di ricerca sul tema "Prognostic markers".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Vedi gli articoli di riviste di molte aree scientifiche e compila una bibliografia corretta.
Kovaleva, Olga V., Madina A. Rashidova, Daria V. Samoilova, Polina A. Podlesnaya, Rasul M. Tabiev, Valeria V. Mochalnikova e Alexei Gratchev. "CHID1 Is a Novel Prognostic Marker of Non-Small Cell Lung Cancer". International Journal of Molecular Sciences 22, n. 1 (5 gennaio 2021): 450. http://dx.doi.org/10.3390/ijms22010450.
Testo completoTaha, Anas, Stephanie Taha-Mehlitz, Stephanie Petzold, Sergey L. Achinovich, Dmitry Zinovkin, Bassey Enodien, Md Zahidul I. Pranjol e Eldar A. Nadyrov. "Prognostic Value of Immunohistochemical Markers for Locally Advanced Rectal Cancer". Molecules 27, n. 3 (18 gennaio 2022): 596. http://dx.doi.org/10.3390/molecules27030596.
Testo completoElias, Jules M. "The Prognosis of Prognostic Markers. Quo Vadis?" Journal of Histotechnology 19, n. 1 (marzo 1996): 7–8. http://dx.doi.org/10.1179/his.1996.19.1.7.
Testo completoVeryaskina, Yuliya Andreevna, Sergei Evgenievich Titov, Igor Borisovich Kovynev, Tatiana Ivanovna Pospelova e Igor Fyodorovich Zhimulev. "Prognostic Markers of Myelodysplastic Syndromes". Medicina 56, n. 8 (27 luglio 2020): 376. http://dx.doi.org/10.3390/medicina56080376.
Testo completoChen, LangXiong, XiaoSong He, ShiJiang Yi, GuanCheng Liu, Yi Liu e YueFu Ling. "Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma". BioMed Research International 2021 (10 febbraio 2021): 1–13. http://dx.doi.org/10.1155/2021/8824195.
Testo completoAlieva, A. M., A. V. Sozykin, N. V. Teplova, E. V. Reznik, D. V. Izimarieva, N. A. Novikova, I. V. Lozovsky, Е. E. Averin, R. K. Valiev e I. G. Nikitin. "Tenascin-C as a cardiovascular marker". Russian Journal of Cardiology 27, n. 8 (3 settembre 2022): 5150. http://dx.doi.org/10.15829/1560-4071-2022-5150.
Testo completoLabussiere, Marianne, Xiao-Wei Wang, Ahmed Idbaih, François Ducray e Marc Sanson. "Prognostic markers in gliomas". Future Oncology 6, n. 5 (maggio 2010): 733–39. http://dx.doi.org/10.2217/fon.10.25.
Testo completoPerkins, Geraldine, Pierre Laurent-Puig e Julien Taieb. "Ampullary carcinoma prognostic markers". Oncotarget 10, n. 44 (16 luglio 2019): 4509–10. http://dx.doi.org/10.18632/oncotarget.27067.
Testo completoBakhshi, Sameer, e Venkatraman Radhakrishnan. "Prognostic markers in osteosarcoma". Expert Review of Anticancer Therapy 10, n. 2 (febbraio 2010): 271–87. http://dx.doi.org/10.1586/era.09.186.
Testo completoRoss, Jeffrey S., Christine E. Sheehan, Hugh AG Fisher, Ronald A. Kauffman, Eric M. Dolen e Bhaskar VS Kallakury. "Prognostic markers inprostate cancer". Expert Review of Molecular Diagnostics 2, n. 2 (marzo 2002): 129–42. http://dx.doi.org/10.1586/14737159.2.2.129.
Testo completoIlhan, A., L. Wagner, M. Maj, A. Woehrer, T. Czech, H. Heinzl, C. Marosi et al. "-Omics and Prognostic Markers". Neuro-Oncology 12, Supplement 4 (21 ottobre 2010): iv61—iv68. http://dx.doi.org/10.1093/neuonc/noq116.s8.
Testo completoMoriera, F., K. So, P. Gould, D. Kamnasaran, R. L. Jensen, I. Hussain, D. H. Gutmann et al. "-OMICS AND PROGNOSTIC MARKERS". Neuro-Oncology 13, suppl 3 (21 ottobre 2011): iii76—iii84. http://dx.doi.org/10.1093/neuonc/nor167.
Testo completoClarke, Martha R., Robert J. Weyant, Charles G. Watson e Sally E. Carty. "Prognostic markers in pheochromocytoma". Human Pathology 29, n. 5 (maggio 1998): 522–26. http://dx.doi.org/10.1016/s0046-8177(98)90070-3.
Testo completoNeidner, Kenneth H. "Analysis of prognostic markers". Clinics in Dermatology 6, n. 1 (gennaio 1988): 116–22. http://dx.doi.org/10.1016/0738-081x(88)90017-x.
Testo completoGoedert, James J. "Prognostic markers for AIDS". Annals of Epidemiology 1, n. 2 (dicembre 1990): 129–39. http://dx.doi.org/10.1016/1047-2797(90)90004-c.
Testo completoConley, Barbara A., e Sheila E. Taube. "Prognostic and Predictive Markers in Cancer". Disease Markers 20, n. 2 (2004): 35–43. http://dx.doi.org/10.1155/2004/202031.
Testo completoKaban, Kübra, Sarah M. Greiner, Samuel Holzmayer, Claudia Tandler, Sophie Meyer, Clemens Hinterleitner, Helmut R. Salih, Melanie Märklin e Jonas S. Heitmann. "Immunoprofiling of 4-1BB Expression Predicts Outcome in Chronic Lymphocytic Leukemia (CLL)". Diagnostics 11, n. 11 (4 novembre 2021): 2041. http://dx.doi.org/10.3390/diagnostics11112041.
Testo completoLi, Limin, Bing Ma, Fubin Liu, Chao Sheng, Yu Peng, Yating Qiao, Peng Wang, Kexin Chen e Fangfang Song. "The Number of Positive Tumor Markers (NPTM) Achieves Higher Value in the Prognosis Prediction of Gastric Cancer". Disease Markers 2022 (28 novembre 2022): 1–13. http://dx.doi.org/10.1155/2022/5145918.
Testo completoLin, Yueh-Min, Mei-Ling Chen, Chia-Lo Chen, Chung-Min Yeh e Wen-Wei Sung. "Overexpression of EIF5A2 Predicts Poor Prognosis in Patients with Oral Squamous Cell Carcinoma". Diagnostics 10, n. 7 (27 giugno 2020): 436. http://dx.doi.org/10.3390/diagnostics10070436.
Testo completoDuffy, M. J. "Biochemical markers as prognostic indices in breast cancer". Clinical Chemistry 36, n. 2 (1 febbraio 1990): 188–91. http://dx.doi.org/10.1093/clinchem/36.2.188.
Testo completoHe, Yanxin, Haiping Song, Yanfang Jiang e Wanhua Ren. "Identification of Immune-Related Prognostic Markers in Gastric Cancer". Journal of Healthcare Engineering 2022 (8 marzo 2022): 1–8. http://dx.doi.org/10.1155/2022/7897274.
Testo completoMontserrat, Emili. "New Prognostic Markers in CLL". Hematology 2006, n. 1 (1 gennaio 2006): 279–84. http://dx.doi.org/10.1182/asheducation-2006.1.279.
Testo completoChua-on, Daraporn, Tanakorn Proungvitaya, Doungdean Tummanatsakun, Anchalee Techasen, Temduang Limpaiboon, Sittiruk Roytrakul, Sopit Wongkham et al. "Apoptosis-Inducing Factor, Mitochondrion-Associated 3 (AIFM3) Protein Level in the Sera as a Prognostic Marker of Cholangiocarcinoma Patients". Biomolecules 10, n. 7 (10 luglio 2020): 1021. http://dx.doi.org/10.3390/biom10071021.
Testo completoRomanenko, T. G., e O. M. Sulimenko. "Modern prognosis markers of preeclampsia". HEALTH OF WOMAN, n. 10(146) (30 dicembre 2019): 77–91. http://dx.doi.org/10.15574/hw.2019.146.77.
Testo completoZhu, Haitao, Xianmin Xiao, Shan Zheng, Yiping Shen e Bai-Lin Wu. "Genetic Prognostic Markers in Neuroblastoma". American Chinese Journal of Medicine and Science 3, n. 3 (2010): 123. http://dx.doi.org/10.7156/v3i3p123.
Testo completoSant'Anna, M. C., L. G. P. Giordano, K. K. M. C. Flaiban, E. E. Muller e M. I. M. Martins. "Prognostic markers of canine pyometra". Arquivo Brasileiro de Medicina Veterinária e Zootecnia 66, n. 6 (dicembre 2014): 1711–17. http://dx.doi.org/10.1590/1678-6859.
Testo completoAlifirova, V. M., E. M. Kamenskikh, E. S. Koroleva, E. V. Kolokolova e A. M. Petrakovich. "Prognostic markers of multiple sclerosis". Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 122, n. 2 (2022): 22. http://dx.doi.org/10.17116/jnevro202212202122.
Testo completoTyrrell, Helen E. J., e David Kerr. "Prognostic markers for colorectal cancer". Oncotarget 9, n. 69 (4 settembre 2018): 33060–61. http://dx.doi.org/10.18632/oncotarget.26012.
Testo completoGomatos, Ilias P., Xu Xiaodong, Paula Ghaneh, Christopher Halloran, Michael Raraty, Brian Lane, Robert Sutton e John P. Neoptolemos. "Prognostic markers in acute pancreatitis". Expert Review of Molecular Diagnostics 14, n. 3 (21 marzo 2014): 333–46. http://dx.doi.org/10.1586/14737159.2014.897608.
Testo completoNavarro, Samuel, Marta Piqueras, Eva Villamón, Yania Yáñez, Julia Balaguer, Adela Cañete e Rosa Noguera. "New prognostic markers in neuroblastoma". Expert Opinion on Medical Diagnostics 6, n. 6 (11 luglio 2012): 555–67. http://dx.doi.org/10.1517/17530059.2012.704018.
Testo completoJuopperi, T. A., D. Bienzle, D. C. Bernreuter, W. Vernau, M. A. Thrall e P. M. McManus. "Prognostic Markers for Myeloid Neoplasms". Veterinary Pathology 48, n. 1 (7 dicembre 2010): 182–97. http://dx.doi.org/10.1177/0300985810389317.
Testo completoVolchkov, E. V., Yu V. Olshanskaya e N. V. Myakova. "Prognostic markers of lymphoblastic lymphoma". Pediatric Hematology/Oncology and Immunopathology 19, n. 4 (22 dicembre 2020): 198–204. http://dx.doi.org/10.24287/1726-1708-2020-19-4-198-204.
Testo completoVajtai, I., e Z. Varga. "Prognostic markers of pleomorphic xanthoastrocytoma". Histopathology 33, n. 4 (ottobre 1998): 391. http://dx.doi.org/10.1046/j.1365-2559.1998.00506.x.
Testo completoGreen, L., Z. Rayter, C. Calder e J. R. Fardon. "Prognostic markers in neoadjuvent chemotherapy". European Journal of Cancer 34 (settembre 1998): S107—S108. http://dx.doi.org/10.1016/s0959-8049(98)80445-0.
Testo completoBurger, Jan A. "Fledgling prognostic markers in CLL". Blood 110, n. 12 (1 dicembre 2007): 3820–21. http://dx.doi.org/10.1182/blood-2007-08-109413.
Testo completoJensen, R. L., S. Abraham, N. Hu, R. L. Jensen, J. L. Boulay, S. Leu, S. Frank et al. "LAB-OMICS AND PROGNOSTIC MARKERS". Neuro-Oncology 14, suppl 6 (1 ottobre 2012): vi91—vi100. http://dx.doi.org/10.1093/neuonc/nos231.
Testo completoMalham, Gregory M., Beth J. Synek, Karen M. Holdaway, Raewyn J. Thomsen, Christopher E. Furneaux e Bruce C. Baguley. "Meningiomas: Prognostic markers for recurrence". Clinical Neurology and Neurosurgery 99 (luglio 1997): S238. http://dx.doi.org/10.1016/s0303-8467(97)82385-2.
Testo completoLeiser, Y., I. Abu-El Naaj, I. Vlodavsky e M. Peled. "O50. Oral cancer prognostic markers". Oral Oncology 47 (luglio 2011): S45. http://dx.doi.org/10.1016/j.oraloncology.2011.06.161.
Testo completoMeyer, Olivier. "Prognostic markers for systemic sclerosis". Joint Bone Spine 73, n. 5 (ottobre 2006): 490–94. http://dx.doi.org/10.1016/j.jbspin.2006.01.022.
Testo completoLeith, Catherine P., e Cheryl L. Willman. "Prognostic markers in acute leukemia". Current Opinion in Hematology 3, n. 4 (1996): 329–34. http://dx.doi.org/10.1097/00062752-199603040-00013.
Testo completoRay, Katrina. "New prognostic markers for CRC". Nature Reviews Clinical Oncology 7, n. 4 (aprile 2010): 182. http://dx.doi.org/10.1038/nrclinonc.2010.29.
Testo completoLeyshon Griffiths, T. R., e David E. Neal. "Prognostic markers in bladder cancer". Current Opinion in Urology 6, n. 5 (settembre 1996): 267–71. http://dx.doi.org/10.1097/00042307-199609000-00008.
Testo completoMoore, David A., J. Howard Pringle e Gerald S. Saldanha. "Prognostic tissue markers in melanoma". Histopathology 60, n. 5 (22 agosto 2011): 679–89. http://dx.doi.org/10.1111/j.1365-2559.2011.03910.x.
Testo completoSorajja, Paul, Kasia Hryniewicz e Peter M. Eckman. "Prognostic Markers and Valve Therapy". JACC: CardioOncology 1, n. 2 (dicembre 2019): 170–71. http://dx.doi.org/10.1016/j.jaccao.2019.11.003.
Testo completoJessup, J. Milburn, e Massimo Loda. "Prognostic markers in rectal carcinoma". Seminars in Surgical Oncology 15, n. 2 (settembre 1998): 131–40. http://dx.doi.org/10.1002/(sici)1098-2388(199809)15:2<131::aid-ssu11>3.0.co;2-5.
Testo completoVroblová, Vladimíra, Lukáš Smolej, Filip Vrbacký, Karolína Jankovičová, Monika Hrudková, Jaroslav Malý e Jan Krejsek. "Biological Prognostic Markers in Chronic Lymphocytic Leukemia". Acta Medica (Hradec Kralove, Czech Republic) 52, n. 1 (2009): 3–8. http://dx.doi.org/10.14712/18059694.2016.99.
Testo completoMatsuguma, H., H. Suzuki, Y. Ishikawa, T. Kondo, R. Nakahara, Y. Kamiyama, K. Mori, T. Kodama e S. Honjo. "Prognostic value of preoperative serum tumor markers, including CEA, Cyfra21–1, SCC, CA19–9, SCC, CA125, TPA, NSE, and SLX, in patients with completely resected pathological stage I non-small cell lung cancer". Journal of Clinical Oncology 25, n. 18_suppl (20 giugno 2007): 7681. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.7681.
Testo completoLi, Huimin, Longxiang Xie, Qiang Wang, Yifang Dang, Xiaoxiao Sun, Lu Zhang, Yali Han et al. "OSmfs: An Online Interactive Tool to Evaluate Prognostic Markers for Myxofibrosarcoma". Genes 11, n. 12 (19 dicembre 2020): 1523. http://dx.doi.org/10.3390/genes11121523.
Testo completoPetekkaya, Hilbrahim, Sercan Aksoy, Gizem Gecmez, Emre Kulahcioglu, Alexis K. Okoh, Deniz Cagın Isler, Abdullah Fatih Demirci, Ugur Sahin, Erkan Dogan e Kadri Altundag. "Inflammatory markers in early-stage breast cancer." Journal of Clinical Oncology 31, n. 15_suppl (20 maggio 2013): e11537-e11537. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e11537.
Testo completoIvanov, Krasimir, Nikola Kolev, Anton Tonev e Anton Tontchev. "Molecular prognostic markers in colorectal cancer." Journal of Clinical Oncology 30, n. 15_suppl (20 maggio 2012): e21100-e21100. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e21100.
Testo completo